1172MO Durvalumab consolidation in patients with stage III non-resecable NSCLC with driver genomic alterations

Authors :: Ernest Nadal
Gilberto Lopes
Laura Mezquita
R. Lopez Castro
Benjamin Besse
J. Mosquera Martinez
E. Escalera Martín
R. Lobefaro
M.R. Garcia Campelo
N. Dempsey
M. Riudavets Melia
Diego Signorelli
M. Tagliamento
Sara Pilotto
M.A. Mosteiro Lamas
J. Bosch Barrera
David Planchard
G. Zalcman
Margarita Majem
Edouard Auclin
Source :: Annals of Oncology. 32:S940-S941
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
Durvalumab
Consolidation (soil)
business.industry
Internal medicine
Medicine
In patient
Hematology
Stage (cooking)
business

Tools